SUBJECTS
|
BROWSE
|
CAREER CENTER
|
POPULAR
|
JOIN
|
LOGIN
Business Skills
|
Soft Skills
|
Basic Literacy
|
Certifications
About
|
Help
|
Privacy
|
Terms
|
Email
Search
Test your basic knowledge |
First Aid Basics
Start Test
Study First
Subjects
:
health-sciences
,
first-aid
Instructions:
Answer 50 questions in 15 minutes.
If you are not ready to take this test, you can
study here
.
Match each statement with the correct term.
Don't refresh. All questions and answers are randomly picked and ordered every time you load a test.
This is a study tool. The 3 wrong answers for each question are randomly chosen from answers to other questions. So, you might find at times the answers obvious, but you will see it re-enforces your understanding as you take the test each time.
1. Erythropoietin
Free radical eliminators
Second - leading cause of death in the US
Chronic inflammatory mediators
paraneoplastic effects of renal cell carcinoma - hemangioblastoma
2. Infections - inflammation - cancer - pregnancy - SLE
bcl -2 gene
L- myc gene
AIDS
causes of increased ESR
3. All - AML
Neoplasm associated with Down Syndrome
paraneoplastic effects of small cell lung carcinoma and intracranial neoplasms
CCl4 target
DCC gene
4. Wilms' tumor 11p tumor suppressor
primary amyloidosis
Prostatic acid phosphatase
Necrosis
WT1 gene
5. Neuroblastoma transcription factor (oncogene)
Autoimmune (Hashimoto's - myasthenia gravis)
N- myc gene
prostate cancer incidence/mortality
Neoplasm associated with chronic atrophic gastritis - pernicious anemia - postsurgical gastric remants
6. TB - fungal infections - syphilis - leprosy - cat scratch fever - sarcoid - Crohn's - Berylliosis.
radiation exposure
TRAP
PSA
granulomatous disease
7. Cancer
smooth muscle benign tumor
Second - leading cause of death in the US
nitrosamines (smoked foods) target
AIDS
8. AA
erb - B2 gene
secondary amyloidosis (reactive systemic)
c - kit gene
breast cancer incidence/mortality
9. Mature teratoma in men or malignant teratoma in M/F
malignant >1 cell type tumor
Where you see Psammoma bodies
Pale infarcts
Second - leading cause of death in the US
10. Tumor marker: neuroblastoma - lung and gastric cancer
L- myc gene
c - kit gene
Bombesin
blood cell malignant tumors
11. Hyperplasia - metaplasia - dysplasia
p53 gene
Reversible - plasias
S-100
paraneoplastic effects of small cell lung carcinoma
12. Breast cancer 13q tumor suppressor (DNA repair protein)
fat malignant tumor
abl gene
BRAC2 gene
skeletal muscle malignant tumor
13. Hepatocellular carcinoma
Alkylating agents target
cirrosis (alcohol - hepB or C)
N- myc gene
paraneoplastic effects of leukemias and lymphomas
14. Lung - liver - intestine or following reperfusion.
extrinsic apoptosis
Red (hemorrhagic) infarcts
malignant epithelial tumor
AIDS
15. Squamous cell carcinoma of the esophagus
causes of increased ESR
bone malignant tumor
Plummer - Vinson syndrome (atrophic glossitis - esophageal webs - anemia)
N- myc gene
16. Female 13% Male 12%
paraneoplastic effects of leukemias and lymphomas
Colon and rectal cancer incidence
Neoplasm associated with xeroderma pigmentosum (albinism)
Autoimmune (Hashimoto's - myasthenia gravis)
17. Esophageal adenocarcinoma
Warning
: Invalid argument supplied for foreach() in
/var/www/html/basicversity.com/show_quiz.php
on line
183
18. Tumor marker: thyroid medullary carcinoma
calcitonin
benign epithelial tumor
skeletal muscle benign tumor
Necrosis
19. Blood (leukemia)
Alkylating agents target
DPC gene
Primary tumors that met to liver
skeletal muscle benign tumor
20. Most human cancers - specifically Li - Fraumeni syndrome 17p tumor suppressor (blocks G1 to S phase progression)
paraneoplastic effects of small cell lung carcinoma and intracranial neoplasms
TRAP
p53 gene
blood cell malignant tumors
21. Neurofibromatosis type 1 17q tumor suppressor
NF1 gene
BRAC2 gene
Acute inflammatory mediators
primary amyloidosis
22. Retinoblastoma - osteosarcoma 13q tumor suppressor (blocks G1 to S phase progression)
Rb gene
Neoplasm associated with xeroderma pigmentosum (albinism)
alpha - fetoprotein
Leukocyte extravasation: diapedesis
23. Tumor marker: mets to bone - obstructive biliary disease - Paget's
bcl -2 gene
Primary tumors that met to bone
Alk - phos
DCC gene
24. Tumor marker: Hydatifiform moles - choriocarcinomas - gestational trophoblastic tumors.
smooth muscle malignant tumor
nitrosamines (smoked foods) target
paraneoplastic effects of renal cell carcinoma - hemangioblastoma
beta - hCG
25. Secondary osteosarcoma and fibrosarcoma
Warning
: Invalid argument supplied for foreach() in
/var/www/html/basicversity.com/show_quiz.php
on line
183
26. Colon>stomach>pancreas>breast>lung (liver and lung are the most common places for mets)
Primary tumors that met to liver
dysplastic nevus
BRAC2 gene
smooth muscle malignant tumor
27. Membrane lipid peroxidation - protein modification and DNA breakage.
asbestos target
malignant >1 cell type tumor
Free radical cell damage
beta - hCG
28. Anaplasia - neoplasia - desmoplasia (fibrous tissue formation in response to neoplasm)
Primary tumors that met to liver
NF2 gene
Irreversible - plasias
bone malignant tumor
29. Solid tissues with single blood supply. Heart - kidney and spleen.
asbestos target
Pale infarcts
primary amyloidosis
acanthosis nigricans (hyperpig and epidermal thickening)
30. Osteoma
bone benign tumor
Irreversible - plasias
beta - hCG
c - kit gene
31. Squamous cell carcinoma of skin
immunodeficiency states
Neoplasm associated with actinic keratosis
DCC gene
Free radical cell damage
32. Breast - ovarian and gastric carcinomas tyrosine kinase (oncogene)
nitrosamines (smoked foods) target
BRAC2 gene
ras gene
erb - B2 gene
33. PECAM-1
Plummer - Vinson syndrome (atrophic glossitis - esophageal webs - anemia)
radiation exposure
Leukocyte extravasation: diapedesis
Alkylating agents target
34. Leiomyosarcoma
Colon and rectal cancer incidence
Bombesin
prostate cancer incidence/mortality
smooth muscle malignant tumor
35. Macrophages and lymphocytes. Persistant destruction and repair.
blood vessels malignant tumor
primary amyloidosis
Leukocyte extravasation: tight binding
Chronic inflammatory mediators
36. Ligand - receptor interactions. Release of perforin and granzyme B.
c - kit gene
Rb gene
CEA
extrinsic apoptosis
37. Colon carcinoma GTPase (oncogene)
DCC gene
alpha - fetoprotein
ras gene
secondary amyloidosis (reactive systemic)
38. Tumor marker: melanoma - neural tumors - astrocytomas
paraneoplastic effects of SqC lung carcinoma - renal cell carcinoma and breast carcinoma.
BRAC2 gene
S-100
N- myc gene
39. Colorectal cancer (assoc with FAP) 5q tumor suppressor
Red (hemorrhagic) infarcts
Primary tumors that met to brain
APC gene
Leukocyte extravasation: diapedesis
40. Malignant melanoma
dysplastic nevus
CEA
Barrett's esophagus (chronic GI reflux)
paraneoplastic effects of SqC lung carcinoma - renal cell carcinoma and breast carcinoma.
41. Breast and ovarian cancer 17q tumor suppressor (DNA repair protein)
BRCA1 gene
Primary tumors that met to liver
immunodeficiency states
Neoplasm associated with chronic atrophic gastritis - pernicious anemia - postsurgical gastric remants
42. Female 13%/23% and rising Male 16%/33% (mortality has plateaued)
lung cancer incidence/mortality
NF2 gene
ras gene
PSA
43. AL
c - kit gene
primary amyloidosis
arsenic target
Leukocyte extravasation: diapedesis
44. Tumor marker: (Normal in fetus). Hepatocellular carcinomas. Nonseminomatous germ cell tumors of the testis.
CA-19-9
primary amyloidosis
ras gene
alpha - fetoprotein
45. Liver (hepatocellular carcinoma)
aflatoxin target
Rb gene
S-100
Irreversible - plasias
46. Mature teratoma in women
Free radical eliminators
Second - leading cause of death in the US
Leukocyte extravasation: migration
benign >1 cell type tumor
47. Rhabdomyosarcoma
Prostatic acid phosphatase
asbestos target
skeletal muscle malignant tumor
smooth muscle malignant tumor
48. Tumor marker: pancreatic adenocarcinoma
CEA
CA-19-9
fat benign tumor
Plummer - Vinson syndrome (atrophic glossitis - esophageal webs - anemia)
49. Papillary (thyroid) - Serous (ovary) - Meningioma - Mesothelioma
Where you see Psammoma bodies
benign epithelial tumor
BRCA1 gene
fat benign tumor
50. ADH
blood vessels benign tumor
CA-19-9
p16 gene
paraneoplastic effects of small cell lung carcinoma and intracranial neoplasms